Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated December 15, 2021, titled "Sun Pharma Announces US FDA Approval for Generic Amphotericin B Liposome Injection".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated December 15, 2021, titled "Sun Pharma Announces US FDA Approval for Generic Amphotericin B Liposome Injection".